The Genomic Landscape of Mucinous Breast Cancer

被引:58
|
作者
Pareja, Fresia
Lee, Ju Youn
Brown, David N.
Piscuoglio, Salvatore
Gularte-Merida, Rodrigo
Selenica, Pier
Paula, Arnaud Da Cruz
Arunachalam, Sasi
Kumar, Rahul
Geyer, Felipe C.
Silveira, Catarina
da Silva, Edaise M.
Li, Anqi
Marchio, Caterina
Ng, Charlotte K. Y.
Mariani, Odette
Fuhrmann, Laetitia
Wen, Hannah Y.
Norton, Larry
Vincent-Salomon, Anne
Brogi, Edi
Reis-Filho, Jorge S.
Weigelt, Britta
机构
[1] Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, 10065, NY
[2] Institute of Pathology, University Hospital Basel, Basel
[3] GenoMed SA, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa
[4] Department of Medical Sciences, FPO-Canndiolo Cancer Institute, University of Turin, Turin
[5] Départment de Médecine Diagnostique et Théranostique, Institute Curie, Paris
[6] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
来源
关键词
CARCINOMA; DIFFERENTIATION; PROGRESSION; TUMORS; PURE;
D O I
10.1093/jnci/djy216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mucinous carcinoma of the breast (MCB) is a rare histologic form of estrogen receptor (ER)-positive/HER2-negative breast cancer (BC) characterized by tumor cells floating in lakes of mucin. We assessed the genomic landscape of 32 MCBs by whole-exome sequencing and/or RNA-sequencing. GATA3 (23.8%), KMT2C (19.0%), and MAP3K1 (14.3%) were the most frequently mutated genes in pure MCBs. In addition, two recurrent but not pathognomonic fusion genes, OAZ1-CSNK1G2 and RFC4-LPP, were detected in 3/31 (9.7%) and 2/31 (6.5%) samples, respectively. Compared with ER-positive/HER2-negative common forms of BC, MCBs displayed lower PIK3CA and TP53 mutation rates and fewer concurrent 1q gains and 16q losses. Clonal decomposition analysis of the mucinous and ductal components independently microdissected from five mixed MCBs revealed that they are clonally related and evolve following clonal selection or parallel evolution. Our findings indicate that MCB represents a genetically distinct ER-positive/HER2-negative form of BC.
引用
收藏
页码:737 / 741
页数:5
相关论文
共 50 条
  • [1] The complex genomic landscape of breast cancer
    Caldas, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 29 - 29
  • [2] The Genomic Landscape of Lobular Breast Cancer
    McCart Reed, Amy E.
    Foong, Samuel
    Kutasovic, Jamie R.
    Nones, Katia
    Waddell, Nicola
    Lakhani, Sunil R.
    Simpson, Peter T.
    CANCERS, 2021, 13 (08)
  • [3] The genomic landscape of Chinese breast cancer
    You, Qiuting
    Zhao, Jianli
    Chen, Kai
    Chen, Yi
    Zeng, Minhua
    Wen, Biaolin
    Ding, Linxiaoxiao
    Su, Fengxi
    CANCER RESEARCH, 2021, 81 (04)
  • [4] The genomic landscape of carcinomas with mucinous differentiation
    Nguyen, Bastien
    Sanchez-Vega, Francisco
    Fong, Christopher J.
    Chatila, Walid K.
    Boroujeni, Amir Momeni
    Pareja, Fresia
    Weigelt, Britta
    Sotiriou, Christos
    Larsimont, Denis
    Reis-Filho, Jorge S.
    Desmedt, Christine
    Schultz, Nikolaus
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] The genomic landscape of carcinomas with mucinous differentiation
    Bastien Nguyen
    Francisco Sanchez-Vega
    Christopher J. Fong
    Walid K. Chatila
    Amir Momeni Boroujeni
    Fresia Pareja
    Britta Weigelt
    Christos Sotiriou
    Denis Larsimont
    Jorge S. Reis-Filho
    Christine Desmedt
    Nikolaus Schultz
    Scientific Reports, 11
  • [6] Genomic Landscape of Breast Cancer Metastasis and Relapse
    Lee, Adrian V.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 591 - 591
  • [7] Surveying germline genomic landscape of breast cancer
    Hemminki, Kari
    Foersti, Asta
    Bermejo, Justo Lorenzo
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (03) : 601 - 603
  • [8] Surveying germline genomic landscape of breast cancer
    Kari Hemminki
    Asta Försti
    Justo Lorenzo Bermejo
    Breast Cancer Research and Treatment, 2009, 113 : 601 - 603
  • [9] The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
    Ellis, Matthew J.
    Perou, Charles M.
    CANCER DISCOVERY, 2013, 3 (01) : 27 - 34
  • [10] Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer
    Wang, S.
    Lu, Q.
    Zhou, H.
    Sun, P.
    Shao, K.
    Lee, K.
    Xu, F.
    Xia, W.
    Jiang, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S312 - S313